A MULTI-VACCINE real-world study in Hungary has proven the high potency and lingering protection of the Russian-made Sputnik V against symptomatic Covid-19.
"With 98 percent efficacy in preventing Covid-related mortality and 85.7 percent efficacy against coronavirus infection, Sputnik V has demonstrated the best results among five vaccines administered in EU-member state Hungary as part of an independent study based on data from 3.7 million people," said Russian Direct Investment Fund (RDIF) President and Chief Executive Officer Kirill Dmitriev.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.